SynKIR-310

· Verismo Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SynKIR-310, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: SynKIR-310 for Relapsed/Refractory B-NHL [Phase 1]